Skip to main content
Elekta logo

Elekta — Investor Relations & Filings

Ticker · EKTA ISIN · SE0000163628 LEI · 54930044O54BK617EP80 ST Manufacturing
Filings indexed 1,124 across all filing types
Latest filing 2012-08-01 Board/Management Inform…
Country SE Sweden
Listing ST EKTA

Elekta is a company specializing in precision radiation medicine. It develops and provides clinical solutions, including equipment and software, for treating cancer and brain disorders. The company's portfolio features linear accelerators, the Elekta Unity MR-Linac system, Leksell Gamma Knife for stereotactic radiosurgery, and comprehensive brachytherapy solutions. Elekta also offers oncology informatics software to support treatment planning and clinical workflow. A key focus is advancing adaptive radiotherapy, a personalized approach that utilizes real-time imaging to precisely target tumors and minimize exposure to healthy tissue, aiming to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Elekta utser Ian Alexander till Executive Vice President Region Europa och Afrika, Latinamerika och Mellanöstern
Board/Management Information Classification · 1% confidence The document is a press release announcing the appointment of Ian Alexander as Executive Vice President for a specific region, effective September 1st. This announcement concerns a change in senior management/board structure. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The content directly aligns with this definition.
2012-08-01 Swedish
Elekta appoints Ian Alexander Executive Vice President Region Europe, Africa, Latin America and Middle East
Board/Management Information Classification · 1% confidence The document is explicitly titled as a "Press Release" and announces a specific personnel change: the appointment of Ian Alexander as Executive Vice President for a major region. This directly aligns with the definition of Board/Management Information (MANG), which covers announcements of changes in senior management. It is not a full financial report (10-K, IR), an earnings announcement (ER), or a dividend notice (DIV). The content focuses entirely on executive appointments.
2012-08-01 English
Antalet utestående aktier i Elekta AB (publ)
Share Issue/Capital Change Classification · 1% confidence The document is a short press release (1822 chars) dated July 31, 2012, titled 'Antalet utestående aktier i Elekta AB (publ)' (The number of outstanding shares in Elekta AB (publ)). It explicitly states that new B-shares were issued due to the exercise of employee stock options and provides the resulting total number of outstanding shares (A and B shares). This directly relates to a change in the company's capital structure via share issuance, which aligns perfectly with the definition of 'Share Issue/Capital Change' (SHA). It is not a comprehensive report (10-K, IR) nor a general announcement (RNS), but a specific notification about share count changes.
2012-07-31 Swedish
Number of outstanding shares in Elekta AB (publ)
Share Issue/Capital Change Classification · 1% confidence The document is a short press release announcing a change in the total number of outstanding shares due to the exercise of employee options. It explicitly states the new total share count and the breakdown between A and B shares. This directly relates to the company's capital structure and share count. Based on the definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category for announcements detailing changes in the number of shares outstanding, even if resulting from option exercises rather than a primary issuance.
2012-07-31 English
Elekta to Incorporate Brainlab Patient Positioning Technology in Therapy Systems to Increase Comfort for Patients with Cancer
Regulatory Filings Classification · 1% confidence The document is a press release announcing a strategic collaboration between Elekta and Brainlab regarding the integration of patient positioning technology into Elekta's therapy systems. It details a business development/partnership, not a mandatory financial filing (like 10-K, ER, or IR). It does not fit the definitions for AGM-R, AR, MANG, CT, CAP, DVA, DLST, DIRS, SR, XLSX, FS, CGR, IRAT, IP, LTR, TAR, MRQ, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. Since it is a general announcement of corporate activity that doesn't fit a more specific category, it falls under the general Regulatory Filings/Announcements category, which is RNS in this schema, as it is a public disclosure made according to securities laws ('The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act...').
2012-07-30 English
Elekta integrerar patientpositioneringsteknik från Brainlab i sina behandlingssystem för ökad bekvämlighet för cancerpatienter
Regulatory Filings Classification · 1% confidence The document is a press release dated July 30, 2012, announcing a strategic integration between Elekta and Brainlab regarding patient positioning technology (ExacTrac) in Elekta's radiation therapy systems. It details a business development/partnership outcome and includes standard boilerplate information about the companies and contact details for Investor Relations and Corporate Communications. This type of announcement, which is not a formal financial report (like 10-K, IR, ER) nor a specific corporate action filing (like DIV, SHA, DIRS), falls best under the general category for regulatory announcements or news releases that don't fit elsewhere. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general corporate news announcement of this nature, as it is a public disclosure mandated by market rules, even if it's not a specific SEC form.
2012-07-30 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.